These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11719269)

  • 1. Phenotypic effects of expanded ataxin-1 polyglutamines with interruptions in vitro.
    Calabresi V; Guida S; Servadio A; Jodice C
    Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):337-42. PubMed ID: 11719269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1.
    Lim J; Crespo-Barreto J; Jafar-Nejad P; Bowman AB; Richman R; Hill DE; Orr HT; Zoghbi HY
    Nature; 2008 Apr; 452(7188):713-8. PubMed ID: 18337722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1.
    Zoghbi HY; Orr HT
    J Biol Chem; 2009 Mar; 284(12):7425-9. PubMed ID: 18957430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice.
    Emamian ES; Kaytor MD; Duvick LA; Zu T; Tousey SK; Zoghbi HY; Clark HB; Orr HT
    Neuron; 2003 May; 38(3):375-87. PubMed ID: 12741986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1.
    Chen HK; Fernandez-Funez P; Acevedo SF; Lam YC; Kaytor MD; Fernandez MH; Aitken A; Skoulakis EM; Orr HT; Botas J; Zoghbi HY
    Cell; 2003 May; 113(4):457-68. PubMed ID: 12757707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegeneration: a question of balance.
    Thompson LM
    Nature; 2008 Apr; 452(7188):707-8. PubMed ID: 18401401
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeting several CAG expansion diseases by a single antisense oligonucleotide.
    Evers MM; Pepers BA; van Deutekom JC; Mulders SA; den Dunnen JT; Aartsma-Rus A; van Ommen GJ; van Roon-Mom WM
    PLoS One; 2011; 6(9):e24308. PubMed ID: 21909428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward cell specificity in SCA1.
    Humbert S; Saudou F
    Neuron; 2002 May; 34(5):669-70. PubMed ID: 12062012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract.
    Yue S; Serra HG; Zoghbi HY; Orr HT
    Hum Mol Genet; 2001 Jan; 10(1):25-30. PubMed ID: 11136710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
    Cummings CJ; Orr HT; Zoghbi HY
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mini-review: spinocerebellar ataxias: an update of SCA genes.
    Trott A; Houenou LJ
    Recent Pat DNA Gene Seq; 2012 Aug; 6(2):115-21. PubMed ID: 22670601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinocerebellar ataxia type 1--modeling the pathogenesis of a polyglutamine neurodegenerative disorder in transgenic mice.
    Clark HB; Orr HT
    J Neuropathol Exp Neurol; 2000 Apr; 59(4):265-70. PubMed ID: 10759181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyglutamine expansion accelerates the dynamics of ataxin-1 and does not result in aggregate formation.
    Krol HA; Krawczyk PM; Bosch KS; Aten JA; Hol EM; Reits EA
    PLoS One; 2008 Jan; 3(1):e1503. PubMed ID: 18231590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias--triple-labeling immunofluorescence study.
    Uchihara T; Fujigasaki H; Koyano S; Nakamura A; Yagishita S; Iwabuchi K
    Acta Neuropathol; 2001 Aug; 102(2):149-52. PubMed ID: 11563629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and clinical correlation in five Indian families with spinocerebellar ataxia 12.
    Srivastava AK; Choudhry S; Gopinath MS; Roy S; Tripathi M; Brahmachari SK; Jain S
    Ann Neurol; 2001 Dec; 50(6):796-800. PubMed ID: 11761478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide models for inherited neurodegenerative disorders: conformation and aggregation properties of long polyglutamine peptides with and without interruptions.
    Sharma D; Sharma S; Pasha S; Brahmachari SK
    FEBS Lett; 1999 Jul; 456(1):181-5. PubMed ID: 10452554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death.
    Okazawa H; Rich T; Chang A; Lin X; Waragai M; Kajikawa M; Enokido Y; Komuro A; Kato S; Shibata M; Hatanaka H; Mouradian MM; Sudol M; Kanazawa I
    Neuron; 2002 May; 34(5):701-13. PubMed ID: 12062018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
    Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
    Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct and accurate measurement of CAG repeat configuration in the ataxin-1 (ATXN-1) gene by "dual-fluorescence labeled PCR-restriction fragment length analysis".
    Lin JX; Ishikawa K; Sakamoto M; Tsunemi T; Ishiguro T; Amino T; Toru S; Kondo I; Mizusawa H
    J Hum Genet; 2008; 53(4):287-295. PubMed ID: 18301861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation.
    Al-Ramahi I; Lam YC; Chen HK; de Gouyon B; Zhang M; Pérez AM; Branco J; de Haro M; Patterson C; Zoghbi HY; Botas J
    J Biol Chem; 2006 Sep; 281(36):26714-24. PubMed ID: 16831871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.